Our proven management team has extensive expertise in the cardiovascular space with robust device development experience. We have strong relationships with global manufacturing partners, a track record of operational excellence, and access to over 3,000 cardiovascular centers in all major geographies.
Incubated by partners of Big Sky Biomedical, FastWave Medical closed on an equity plus milestone-based acquisition agreement within 6 months of forming the company, which ranks as one of the fastest deals in the history of medtech.
Our first portfolio company, Crossfire Medical is focused on the $1B+ chronic venous insufficiency market and is developing innovative non-tumescent, non-thermal devices as well as cost-effective endovenous radiofrequency ablation catheters.
Our team is actively working on several stealth projects in the interventional arena. If you’re interested in partnering with a group of entrepreneurs that are biased towards execution, stack the odds in your favor and reach out below.
